Stockreport

Jasper Therapeutics Announces Pricing of $50 Million Underwritten Offering of Common Stock [Yahoo! Finance]

Jasper Therapeutics, Inc. - Class A  (JSPR) 
PDF focused on developing novel antibody therapies targeting c-Kit (CD117) to address diseases such as chronic spontaneous urticaria (CSU) and lower to intermediate risk mye [Read more]